PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development

LAGUNA HILLS, Calif., Feb. 8, 2024 -- (Healthcare Sales & Marketing Network) -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced the appointment of Chris Emery to the... Diagnostics, Oncology, Personnel PreludeDx, DecisionTree
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news